The Next Step in Europe
Join us for the first-ever Cannabis Europa in Spain, to discuss the most pertinent questions for Spanish and European industries.
José Antonio de la Puente has been the CEO of Alcaliber S.A.U. since 2004. Alcaliber is a leading independent supplier of active pharmaceutical ingredients for the international pharmaceutical industry. He is also the CEO of Linneo Health since October 2018, a Spanish Company founded for the activities of cultivation, production, manufacturing, import, export, distribution and trade of cannabis and cannabis products for medical and scientific purposes, as well as research linked to the development of these activities.
Javier Fernández-Ruiz is Professor in the Department of Biochemistry and Molecular Biology, Faculty of Medicine at the Complutense University of Madrid. He is currently the Principal Investigator of the “Cannabinoids and Neurological Disorders” research group at the Complutense University. The main activity of this group is the study of the therapeutic potential of cannabinoids in several neurological diseases, mainly neurodegenerative, activity addressed to the design, synthesis and biological characterization of novel cannabinoids with neuroprotective profile, and to test their therapeutic efficacy at preclinical and clinical levels. Professor Fernandez is also a member of the Editorial Board in the British Journal of Pharmacology.
Carola Pérez has a degree in Audiovisual Communication, a field to which she has dedicated most of her professional life. She currently chairs the Spanish Medicinal Cannabis Observatory and is the founder of the association of therapeutic users dosemociones, where she advises, supports all those patients who use cannabis for medicinal purposes and works for the regulation of therapeutic cannabis.
Sarah Meryll Buet started her career in capital markets between London & Paris, where she has developed a passion for Sciences & Innovation. After having helped to develop Alkion BioPharma, Sarah founded Alkion BioInnovations (Alkinnov), a biotech company developing innovative GMO-free plant-based active ingredients using sustainable patented biotechnologies.
Bruno Maia is a Portuguese MD, specialist in Neurology and Critical Care Medicine. He works in the acute care of stroke patients and is responsible for the Neurovascular Ultrasonographic Laboratory at Centro Hospitalar de Lisboa Central (terciary hospital located in Lisbon).
Viola Brugnatelli is the scientific director of Cannabiscienza, an e-learning academy for Italian health care professionals on Medical Cannabis and the Endocannabinoid System. Dr Brugnatelli is a lecturer on Medical Cannabis at the University of Padua (Italy) as well as a researcher at the Department of Neuroscience within the same institute. Since 2012 she is an active member of IACM and ICRS, and was recently nominated IACM Italian Ambassador. Dr Brugnatelli advocates for patient-inspired clinical research and collaborates with non-for-profit organisations. In 2018 Brugnatelli co-founded a non-for-profit which lobbies for women equality in the European cannabis sphere.
Dr Tina Horsted is a doctor who specialises in prescribing medicinal cannabis. Two years ago, she started the public pain clinic Min Smerte. Dr Horsted and her team treat more than 1,200 patients in their clinic who suffer from chronic pain, MS, RA and cancer.
Stephen Murphy is Co-Founder of NOBL Group, a global leader in cannabis data and media. Stephen is also Co-Founder of Prohibition Partners, the leading source of intelligence and insights into the European cannabis industry. He is also Co-Founder of Cannabis Europa.
Spain represents Europe’s largest cannabis market yet to legalise medical cannabis. However, with strong social support fueling a shift in the political debate and changes abound across the continent, reform is inevitable. With 84% of the population in favour of medical cannabis, a burgeoning commercial industry and one of the most innovative biomedical sectors in the world, Spain is fast becoming the most promising industry in the region.
Learn, Network, Debate
Cannabis Europa Madrid will bring together 250+ senior decision-makers to address the issues of regulating cannabis in Spain and around Europe.
- Attend a balance of political, scientific and business discussions led by esteemed moderators and carefully curated panels
- Network with country delegations comprising thought-leading politicians, regulators, patient advocates, medical practitioners and researchers in order to shape the future of medical cannabis in Europe
- Discover the latest European investment opportunities and trends in the world’s fastest-growing cannabis market.
Reserve your seat today to avoid disappointment.
*Early Bird Tickets available until 31st December 2019. These tickets are limited and subject to availability.
Join us to discover the latest news from the European cannabis sector, learn from our world-renowned speakers and network with industry-leading professionals.
Cannabis Europa Madrid will be taking place at the Intercontinental Hotel, in the heart of Madrid.
Paseo de la Castellana, 49, 28046 Madrid, Spain
The venue is a 20 minute drive from Madrid-Barajas Adolfo Suárez Airport and a 40 minute journey via public transport.